Industry · AI strategy
Library › Industries › Life Sciences & Pharmaceuticals
Life Sciences & Pharmaceuticals AI Strategy: opportunities, use cases & the operating model
In pharma, AI's value concentrates in R&D and safety: compressing discovery timelines, sharpening trial design and recruitment, and industrializing pharmacovigilance, where each avoided delay is worth exclusivity-period revenue.
Where AI creates value
Target identification — Multi-omics and literature-driven target discovery
Molecule design — Generative chemistry and property prediction
Trial design — Protocol optimization and synthetic control arms
Patient recruitment — Site selection and eligibility matching at scale
Pharmacovigilance — Adverse event intake, coding, and signal detection
Regulatory and medical writing — Submission and CSR document generation
Top AI use cases
- Generative and structure-based design proposing candidate molecules with predicted ADMET
- Trial protocol optimization and feasibility using historical and real-world data
- Patient recruitment matching eligibility against EHR and registry populations
- Automated adverse event case intake, MedDRA coding, and safety signal detection
- Medical writing copilots drafting clinical study reports and regulatory submissions
What has to change (operating model)
- GxP validation and computer system validation extended to AI and machine learning models
- FDA and EMA expectations for transparency and evidence in AI-supported submissions
- Pharmacovigilance QPPV accountability for AI-assisted signal detection and reporting
- Data governance for real-world data provenance and patient privacy across R&D
Get the governed Life Sciences & Pharmaceuticals pack.
Governed, AI-mapped deliverables with worked examples — review, adapt & activate in 48 hours.